Literature DB >> 32473390

South Indian medicinal plants can combat deadly viruses along with COVID-19? - A review.

Mani Divya1, Sekar Vijayakumar2, Jingdi Chen3, Baskaralingam Vaseeharan4, Esteban F Durán-Lara5.   

Abstract

SARS-CoV-2 is a causative agent of Coronavirus disease-19 (COVID-19), which is considered as a fatal disease for public health apprehension worldwide. This pathogenic virus can present everywhere. As it is a virus it can extend easily and cause severe illness to humans. Hence, an efficient international attentiveness of plan is necessary to cure and prevent. In this review, epidemic outbreak, clinical findings, prevention recommendations of COVID-19 and suggestive medicinal value of south Indian plant sources have been discussed. Though the varieties of improved approaches have been taken in scientific and medicinal concern, we have to pay attention to the medicinal value of the plant-based sources to prevent these types of pandemic diseases. This is one of the suggestive and effective ways to control the spreading of viruses. In the future, it is required to provide medicinal plant-based clinical products (Masks, sanitizers, soap, etc.,) with better techniques by clinicians to contend the scarcity and expose towards the nature-based medicine rather than chemical drugs. This may be a benchmark for the economical clinical trials of specific plant material to treat the viral diseases in the future.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COVID-19; Pandemic; Prevention; South indian medicinal plants

Mesh:

Year:  2020        PMID: 32473390      PMCID: PMC7253980          DOI: 10.1016/j.micpath.2020.104277

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


COVID-19

A novel coronavirus (nCoV) is identified as a pathogen and causes some illness which leads to death cause of massive alveolar injure and progressive respiratory stoppage [1]. From the time of when 2019 month of December, the novel coronavirus disease (nCoV) has to turn out to be a major pandemic threat in china and all over the world [2]. It is named as 2019-nCoV through World health organization (WHO) formally. 2019-nCoV recognized as etiological representative of the disease and phylogenetic testing of the virus was differs from formerly acknowledged corona viruses [3]. Recently, information regarding the epidemiology and medical features of pneumonia originated with 2019-nCoV is very scanty. The patients of 2019-nCoV pneumonia was confirmed and admitted headed for Jinyintan hospital, Wuhan; first patient with 2019-nCoV to be reported resting on [4]. Coronavirus is the source of multiple system infection in the range of animals and severe respiratory tract infections among humans including severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). On the root of phylogenetic analysis linked with coronaviruses, the International committee on virus taxonomy published a script on bioRxiv. Jiang et al. [5], suggested an assigned 2019-nCoV severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) like WHO renamed a disease of coronavirus (COVID-19). The Middle East respiratory syndrome is originated with 2019-nCoV (MERS-CoV), which has been isolated at first in the Saudi in 2012 from respiratory tract discharge, a person who died from as of viral pneumonia [6]. COVID-19 that cause respiratory, enteric and central nervous system in many species as in humans too. These are noted as enveloped, positive-sense, single-stranded RNA viruses with a genus of Coronaviridae family. These genomic RNA is 27–32 kb in size and polyadenylated [7] (Fig. 1 ).
Fig. 1

Model structure of the nCoV.

Model structure of the nCoV.

Epidemic outbreak

The nCoV belongs to the linkage B of genus Beta coronavirus which is phylogenetically related with close enough to bat SARS- alike coronaviruses [8]. In history, nCoV is one another exceedingly pathogenic coronavirus enroute for human. The virus has its own high transmission ability as well as towering mobility and transience and so it has lift up world apprehension [9]. Hence, it is very hard in management for public health care and physician in this outbreak. Earlier categorization of patients is an essential way to take control measures of these pandemics while urgent situation management has to be accomplishing in some outbreaks as like SARS and 2019-nCoV [10]. Hospital based outbreaks are notorious to involving human to human transmission of spread can be arrested by some of the control measures [11]. China has determined on habitual public health outburst with; quarantine, isolation and social hostility [12]. Likewise the current outbreak of nCoV gives many provinces of china in concern China medicine (CM) with managing and preventing events are mainly to know about Oral Chinese herbal medicine formulae. This is in need to provide regulation for the prevention of the virus outbreak [13]. At present, the decisive effect of this outbreak is indistinct as it growing rapidly. For this problematic condition, it can be clear with prevention steps are much important to take by public, before the eruption must be defeated; yet another viral pathogen emerging in role with a challenge to humans (Table 1 ).
Table 1

At the time of preparing this manuscript as on 25th May 2020 a tabular data accurate with the following information of affected people with COVID-19.

S. NoCountryAffectedDeathRecovered
1.United states1,689,61899,381451,745
2.Spain282,85228,752196,958
3.Italy229,85832,785140,479
4.France182,58428,36764,617
5.India141,228405758,727
6.Iran137,7247451107,713
7.China82,985463478,268
8.Singapore31,9602314,876
9.Southkorea11,20626710,226
10.Thailand3042572928
At the time of preparing this manuscript as on 25th May 2020 a tabular data accurate with the following information of affected people with COVID-19.

Sign and clinical outcomes

Symptoms

For nCoV the symptoms of infection become visible approximately after an incubation period of 5.2 days [14]. The inceptions of nCoV with most common symptoms are cough, fever, headache, sore throat, diarrhea, rhinorrhoea, sneezing, hypoxemia [9,[15], [16]], and recently anosmia (Fig. 2 ).
Fig. 2

Illustrative representation of the nCoV symptoms.

Illustrative representation of the nCoV symptoms.

Diagnosis

For diagnosis, Wang et al. (2020) [17] described the majority of 41 patients confirmed with diagnosis of lower respiratory tract sample to detect the RNA viral detection. Adding up with nucleic acid tests as the diagnosis (Collection of blood, nasal and throat swabs) of COVID-19 pneumonia; it undergoes several clinical examinations such as chest CT, blood counts, medical history of the affected person and exposure to the specific symptoms. Besides, Remdesivir (RDV), this could inhibit corona infection invitro. RDV is a novel nucleotide analogue proved to be an effective Pan-CoV [18,19] antiviral. Recently, a phase 3 clinical trial of secure and protective effect of RDV is ongoing in Wuhan [20]. Real time reverse transcriptase (RT-PCR) detection is advantages as specific detecting methods of coronavirus, which has been diagnosed as helpful in the way of early infections [21]. This assay is still leading method to be applied for detecting coronavirus (All type) [[22], [23], [24]]. The broad spectrum of an antiviral medicine such as nucleoside analogues and HIV protease inhibitors could attenuated these infectious virus in anticipation of specific antiviral befall accessible [25]. Further, the clinical agent EIDD-2801 has high therapeutic efficiency against pandemic viral infection as it to be considered for the treatment of COVID-19 [26]. Preclinical basis effectiveness of chloroquine for to treat COVID-19, it is safety from long term usage medical proven customs [27]. According to Cortegiani et al. [28], high quality clinical trials from various locations are needed in emergency worldwide for COVID-19.

Prevention recommends for 2019-nCoV

WHO is subjecting counsel on preventing the spread of COVID-19 [29]. They advise to avoid travel at highly risk areas as well as to prevent the entry of the people who are from closely affected region, consuming meat from known nCoV affected province and contact with symptomatic individuals [30]. Personal hygiene can be determining the self as well as society health. Cleaning hands with soap than using sanitizer can reduce the risk of viruses on hand and washed out when it's used frequently as specific after using the bathroom, coughing, and sneezing [31]. Using of face masks is also important to prevent the entry of pathogens via the respiratory system [32]. For huge community social distancing could be maintained to reduce the interaction of the public [33]. Symptom checker is used for the preventive channel for the 2019-nCoV outbreak [34] (Fig. 3).
Fig. 3

Preventive measures to stop spreading nCoV.

Preventive measures to stop spreading nCoV.

Natural medicine to control virus

South Indian medicine for the control of virus

Spread of infection while epidemic can be controlled with persuasive antiviral herbal interference. India has prosperous and unique collection of plants an estimated 45,000 species of plants have been used in traditional medicine systems [35]. Tamilnadu is one of the mainly botanized zones of south India. The medicinal properties of plants were analyzed with various types of researchers in Tamilnadu. It is for the documentation and provides wide information concerning the medicinal plant from traditional healers to protect the fact of plant usage [36]. Traditional plants used in India in relation to 4000 years getting on. Herbal plants have been used by all cultures throughout history. A mainstream of global population in developing and squat earning countries relies for primary health care using traditional medicine [37]. An extensive assortment of pharmaceutical attention has been expressed in plants widely. Plant based vaccines are being evaluated in clinical trials for influenza, hepatitis B etc., [38]. People have been used medicinal plants to cure severe disease habitually and also Indian medicinal plants have been examined for antiviral properties [39]. Only some reported on plants from Tamilnadu in spite of the plants used by many tribal people throughout for the management of viral infections [40]. More than 85% of individuals in developing countries use these medicines for health concern [41]. It is stressed necessitate for further investigation and incorporation towards modern plant based medicines (Table 2 ).
Table 2

List of south Indian medicinal plants inhibits several types of viruses.

Indian Medicinal plants (South)VirusEffectivenessReference
Azadirachta indicaDengue virusLeaf extract (Aqueous) inhibits DEN-2 in vivoParida et al., 2002 [42]
Hippophae rhamnoidesDengue virusLeaf extract has significant anti-dengue activityMonika et al., 2008 [43]
Andrographis paniculataNilavembu kudineer (NVK)Dengue virusChikungunya virus (CHIKV)NVK provides protection against DENV and CHIKVJain et al., 2019 [44]
Glycine max (black)Human adenovirus (type 1)Inhibits human ADV-1 in dose dependant mannerYamai et al., 2003 [45]
Ficus religiosaHuman rhino virus (HRV) & Respiratory syncytial virus (RSV)Bark extract endowed with antivirus activity against HRV & RSVCagno et al., 2015 [46]
Sesbania grandifloraHerpes simplex virusExtract possess strong antiviral against HSVArthanari et al., 2012 [47]
Carissa edulisHerpes simplex virusExhibits anti HSV-1&2 invitro and in vivo stronglyTolo et al., 2006 [48]
Achyranthus asperaHerpes simplex virusInhibits earlier stages of HSV multiplicationsMukerjee et al., 2013 [49]
Guazuma ulmifolia LamPolio virusExtracts inhibits polio replicationsDeFelipe et al., 2006 [50]
Punica granatum LHuman herpes virus-3Phytochemical extract exhibits potential anti viral activityAngamuthu et al., 2019 [51]
Phyllanthus amarusHuman immuno deficiency virusInhibits HIV replicationNotka et al., 2004 [52]
Hepatitis B virusPlant extract had lost HBV antigen surfaceThyagarajan et al., 1988 [53]
Avicennia marinaHepatitis B virusInhibits HBV antigenBeula et al., 2012 [54]
Terminalia bellericaHIV-1Pseudo virusesPlant extract against HIV-1Jayasundar et al., 2019 [55]
Canthium coromandelicumHIVLeaf extract control HIV infectionsChinnaiyan et al., 2013 [56]
Moringa oleiferaHIVLeaves used to inhibit viral replicationEze et al., 2014 [57]
Epstein bar virus (EBV)Leaves and seeds inhibits activity against EBV activationMurakami et al., 1998 [58]
List of south Indian medicinal plants inhibits several types of viruses.

Conclusion

The impression of plant based medicine constitutes an applicable way for the expansion of vaccines with attractive features. Seeing as noteworthy add up to plant extracts have capitulate positive outcomes it seems reasonable potential antiviral agents so far reported. The pharmacological characteristic of major south Indian medicinal plants further needs to investigate the exploration of producing vaccines to treat several viral diseases. It is very important these plant based concern not only focused on vaccines and medicines but also the plant based coated clinical equipments like masks, soap and sanitizers etc., As the review concluded the plant based sources has may have the ability to kill the viral based diseases so far, hence it is proven that variety of plant compounds yet to be examined for future invention for the control of COVID-19 like deadly diseases. The unknown fact and formulae about the effectiveness of some plants may be there, therefore medicinal plant and its compound may have the ability to fight against 19-nCoV.

Declaration of competing interest

Authors declares no conflict of interest.
  46 in total

1.  Antiviral effect of Guazuma ulmifolia and Stryphnodendron adstringens on poliovirus and bovine herpesvirus.

Authors:  Adriana Meri Mestrimer Felipe; Vinicius Pires Rincão; Fabrício José Benati; Rosa Elisa Carvalho Linhares; Karen Janaina Galina; Cleyton Eduardo Mendes de Toledo; Gisely Cristiny Lopes; João Carlos Palazzo de Mello; Carlos Nozawa
Journal:  Biol Pharm Bull       Date:  2006-06       Impact factor: 2.233

2.  Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus.

Authors:  S P Thyagarajan; S Subramanian; T Thirunalasundari; P S Venkateswaran; B S Blumberg
Journal:  Lancet       Date:  1988-10-01       Impact factor: 79.321

3.  Effect of Hippophae rhamnoides leaf extract against Dengue virus infection in human blood-derived macrophages.

Authors:  Monika Jain; L Ganju; A Katiyal; Y Padwad; K P Mishra; S Chanda; D Karan; K M S Yogendra; R C Sawhney
Journal:  Phytomedicine       Date:  2008-06-30       Impact factor: 5.340

4.  A Melting Curve-Based Multiplex RT-qPCR Assay for Simultaneous Detection of Four Human Coronaviruses.

Authors:  Zhenzhou Wan; Ya'nan Zhang; Zhixiang He; Jia Liu; Ke Lan; Yihong Hu; Chiyu Zhang
Journal:  Int J Mol Sci       Date:  2016-11-23       Impact factor: 5.923

Review 5.  Middle East respiratory syndrome coronavirus: review of the current situation in the world.

Authors:  Michael Shapiro; Beny London; Daniel Nigri; Alon Shoss; Eyal Zilber; Itay Fogel
Journal:  Disaster Mil Med       Date:  2016-05-04

6.  Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.

Authors:  Maria L Agostini; Erica L Andres; Amy C Sims; Rachel L Graham; Timothy P Sheahan; Xiaotao Lu; Everett Clinton Smith; James Brett Case; Joy Y Feng; Robert Jordan; Adrian S Ray; Tomas Cihlar; Dustin Siegel; Richard L Mackman; Michael O Clarke; Ralph S Baric; Mark R Denison
Journal:  mBio       Date:  2018-03-06       Impact factor: 7.867

7.  Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.

Authors:  Li-Li Ren; Ye-Ming Wang; Zhi-Qiang Wu; Zi-Chun Xiang; Li Guo; Teng Xu; Yong-Zhong Jiang; Yan Xiong; Yong-Jun Li; Xing-Wang Li; Hui Li; Guo-Hui Fan; Xiao-Ying Gu; Yan Xiao; Hong Gao; Jiu-Yang Xu; Fan Yang; Xin-Ming Wang; Chao Wu; Lan Chen; Yi-Wei Liu; Bo Liu; Jian Yang; Xiao-Rui Wang; Jie Dong; Li Li; Chao-Lin Huang; Jian-Ping Zhao; Yi Hu; Zhen-Shun Cheng; Lin-Lin Liu; Zhao-Hui Qian; Chuan Qin; Qi Jin; Bin Cao; Jian-Wei Wang
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

8.  The first 2019 novel coronavirus case in Nepal.

Authors:  Anup Bastola; Ranjit Sah; Alfonso J Rodriguez-Morales; Bibek Kumar Lal; Runa Jha; Hemant Chanda Ojha; Bikesh Shrestha; Daniel K W Chu; Leo L M Poon; Anthony Costello; Kouichi Morita; Basu Dev Pandey
Journal:  Lancet Infect Dis       Date:  2020-02-10       Impact factor: 25.071

9.  What are the risks of COVID-19 infection in pregnant women?

Authors:  Jie Qiao
Journal:  Lancet       Date:  2020-02-12       Impact factor: 79.321

Review 10.  Recent advances and perspectives of nucleic acid detection for coronavirus.

Authors:  Minzhe Shen; Ying Zhou; Jiawei Ye; Abdu Ahmed Abdullah Al-Maskri; Yu Kang; Su Zeng; Sheng Cai
Journal:  J Pharm Anal       Date:  2020-03-01
View more
  9 in total

Review 1.  A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review.

Authors:  Priyanka Dash; Subhashree Mohapatra; Sayantan Ghosh; Bismita Nayak
Journal:  Front Pharmacol       Date:  2021-02-26       Impact factor: 5.810

Review 2.  Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19.

Authors:  Hassan A Alhazmi; Asim Najmi; Sadique A Javed; Shahnaz Sultana; Mohammed Al Bratty; Hafiz A Makeen; Abdulkarim M Meraya; Waquar Ahsan; Syam Mohan; Manal M E Taha; Asaad Khalid
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

3.  Immunotherapies and immunomodulatory approaches in clinical trials - a mini review.

Authors:  Mohd Iqbal Yatoo; Zeenat Hamid; Izhar Rather; Qurat Ul Ain Nazir; Riyaz Ahmed Bhat; Abrar Ul Haq; Suhail Nabi Magray; Zulfqar Haq; Ranjit Sah; Ruchi Tiwari; SenthilKumar Natesan; Muhammad Bilal; Harapan Harapan; Kuldeep Dhama
Journal:  Hum Vaccin Immunother       Date:  2021-02-12       Impact factor: 3.452

4.  In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease.

Authors:  Islam Mostafa; Nashwa Hashem Mohamed; Basant Mohamed; Rafa Almeer; Mahmoud M A Abulmeaty; Simona G Bungau; Assem Mohamed El-Shazly; Galal Yahya
Journal:  Environ Sci Pollut Res Int       Date:  2021-12-02       Impact factor: 5.190

5.  Screening of potential inhibitors of COVID-19 with repurposing approach via molecular docking.

Authors:  Negin Alizadehmohajer; Abtin Behmardi; Simin Najafgholian; Shabnam Moradi; Forogh Mohammadi; Reza Nedaeinia; Shaghayegh Haghjooy Javanmard; Ehsan Sohrabi; Rasoul Salehi; Gordon A Ferns; Asieh Emami Nejad; Mostafa Manian
Journal:  Netw Model Anal Health Inform Bioinform       Date:  2022-02-04

Review 6.  Antiviral Plants from Marajó Island, Brazilian Amazon: A Narrative Review.

Authors:  Paulo Wender P Gomes; Luiza Martins; Emilli Gomes; Abraão Muribeca; Sônia Pamplona; Andrea Komesu; Carissa Bichara; Mahendra Rai; Consuelo Silva; Milton Silva
Journal:  Molecules       Date:  2022-02-24       Impact factor: 4.411

Review 7.  A Review with Updated Perspectives on the Antiviral Potentials of Traditional Medicinal Plants and Their Prospects in Antiviral Therapy.

Authors:  Nur Fadlin Saifulazmi; Emelda Rosseleena Rohani; Sarahani Harun; Hamidun Bunawan; Hamizah Shahirah Hamezah; Nor Azlan Nor Muhammad; Kamalrul Azlan Azizan; Qamar Uddin Ahmed; Sharida Fakurazi; Ahmed Mediani; Murni Nazira Sarian
Journal:  Life (Basel)       Date:  2022-08-22

Review 8.  Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2.

Authors:  Arumugam Vijaya Anand; Balasubramanian Balamuralikrishnan; Mohandass Kaviya; Kathirvel Bharathi; Aluru Parithathvi; Meyyazhagan Arun; Nachiappan Senthilkumar; Shanmugam Velayuthaprabhu; Muthukrishnan Saradhadevi; Naif Abdullah Al-Dhabi; Mariadhas Valan Arasu; Mohammad Iqbal Yatoo; Ruchi Tiwari; Kuldeep Dhama
Journal:  Molecules       Date:  2021-03-22       Impact factor: 4.411

Review 9.  Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: a review.

Authors:  C S Sharanya; A Sabu; M Haridas
Journal:  Futur J Pharm Sci       Date:  2021-06-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.